Fluoroquinolones (FQs) are one of the most prescribed classes of antibiotics that include Levaquin, Avelox, Cipro, Noroxin, Floxin, Factive and generic versions of these same drugs. Experts say these drugs are overprescribed – 5 prescriptions are written for each 6 Americans annually – it is likely you have taken FLQs in your lifetime.
Studies link these antibiotics to a 2-fold increase of aortic aneurysms and aortic dissections. In addition, the FDA may soon warn consumers that FQs carry the risk of peripheral neuropathy and a severe, disabling, multi system disability in previously healthy individuals described by and FDA Advisory Report as Fluoroquinolones-associated-disability (FQAD).
The manufacturers of these antibiotics did not properly warn of the risk of aortic aneurysms, aortic dissections, peripheral neuropathy or FQAD. Many previously healthy individuals believe antibiotic treatments led to life altering symptoms.
TruLaw is currently filing lawsuits on behalf of individuals who experienced an aortic dissection, aortic aneurysm or have been diagnosed with peripheral neuropathy.
TruLaw is also currently analyzing the possibility of filing cases on behalf of individuals who experienced “a constellation of symptoms” from antibiotics. FDA Advisory notes refer to this “constellation of symptoms as Fluoroquinolones-Associated Disability (FQAD) although many other terms have been used to describe individuals experiencing numerous side effects they believe were linked to their use of FQs. According to the FDA, a diagnosis with this disability requires the following:
A previously healthy patient who was prescribed a course of FQs for the treatment of one of the following:
Multiple Specific Symptoms
Symptoms relating to at least two different body systems, which may include:
Symptoms Persist After Treatment
Symptoms need to have been reported to last 30 days or longer after stopping the FQ treatment
Case studies now clearly indicate that previously healthy individuals with no prior medical history can develop life-altering symptoms while on FQs and even after stopping the course of medication!
The FDA refers to FQAD’s side effects as a “constellation of symptoms.” They occur across multiple body systems including musculoskeletal, cardiac, dermatologic, neurologic and neuro-psychiatric risks.
TruLaw is currently filing cases on behalf of individuals who took fluoroquinolones and were diagnosed with an aortic aneurysm, aortic dissection, peripheral neuropathy and FQAD and want to hold the manufacturers responsible for their injuries.